NCT03596346 (RYPSI-ING) is a NA clinical trial of Rapeseed ingredient (RI) in Food Safety, sponsored by Avena Nordic Grain Oy.

Who is sponsoring NCT03596346?

NCT03596346 is sponsored by Avena Nordic Grain Oy.

What drugs are being tested in NCT03596346?

Interventions in NCT03596346: Rapeseed ingredient (RI), Control product without added RI.

What condition does NCT03596346 study?

NCT03596346 studies Food Safety.

Is NCT03596346 still recruiting?

NCT03596346 is currently completed. Last updated 30 November 2018.

Last reviewed 2018-11-30 · How we verify

NCT03596346: RYPSI-ING

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Safety and Tolerability of a Rapeseed Food Ingredient

Completed NA Last updated 30 November 2018

What this trial tests

NA trial testing Rapeseed ingredient (RI) in Food Safety in 54 participants. Completed in 25 October 2018.

Timeline

4 July 2018

Primary endpoint
25 October 2018

25 October 2018

Quick facts

Lead sponsor	Avena Nordic Grain Oy
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	54
Start date	4 July 2018
Primary completion	25 October 2018
Estimated completion	25 October 2018
Sites	1 location across Finland

Drugs / interventions tested

Rapeseed ingredient (RI)
Control product without added RI

Conditions studied

Food Safety — all drugs for Food Safety →

Sponsor

Avena Nordic Grain Oy

Who can join

Adults 18 to 75, any sex, with Food Safety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is designed to assess the safety and tolerability of a novel food ingredient produced from rape seeds supplied as a snack-bar in a 4-week controlled intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03596346 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Avena Nordic Grain Oy
Last refreshed: 30 November 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03596346.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing